[Predictive and prognostic factors for the chemoradiotherapy of rectal cancer].
Department of Radiology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital.
Katsuyuki
K
Karasawa
D002455:Cell Division; D059248:Chemoradiotherapy; D018773:Genes, erbB-1; D019394:Ki-67 Antigen / Q000032:analysis; D011379:Prognosis; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis; D012004:Rectal Neoplasms / Q000628:therapy*; D016896:Treatment Outcome; D016159:Tumor Suppressor Protein p53 / Q000032:analysis; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics
D019394:Ki-67 Antigen; D018809:Proliferating Cell Nuclear Antigen; D016159:Tumor Suppressor Protein p53; D042461:Vascular Endothelial Growth Factor A